South Cone Investments Limited Partnership, 10% Owner at Rani Therapeutics Holdings, Inc. (RANI), bought 25,800 shares at $5.98 ($154K) on 2022-12-30, disclosed to the SEC on 2023-01-03.
Open-market purchase of $154k RANI by 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $5.97 | 8,600 | $51K | 33.3% |
| 2 | $5.98 | 8,600 | $51K | 33.4% |
| 3 | $5.98 | 8,600 | $51K | 33.4% |
| Total | $5.98 avg | 25,800 | $154K | 100% |
| Filing → |
| RANI | BUY | 2023-12-08 | $21.2M | — | Filing → |
| RANI | BUY | 2023-05-05 | $10K | — | Filing → |
| RANI | BUY | 2023-05-02 | $10K | — | Filing → |